Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 9, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-29
DOI
10.1038/s41419-020-03009-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
- (2019) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucocorticoids promote breast cancer metastasis
- (2019) Milan M. S. Obradović et al. NATURE
- Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways
- (2019) Hanna Karvonen et al. Cells
- ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors
- (2019) Katja Kaipio et al. JOURNAL OF PATHOLOGY
- The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer
- (2018) Vladimir Djedovic et al. Hormones & Cancer
- Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
- (2018) Jin-Ku Lee et al. NATURE GENETICS
- Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies
- (2018) K Veskimäe et al. Translational Oncology
- DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death
- (2018) Benoît Thibault et al. Scientific Reports
- High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer
- (2017) Jennifer Taylor Veneris et al. GYNECOLOGIC ONCOLOGY
- Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis
- (2017) Claire Henry et al. Oncotarget
- Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination
- (2017) Yuliya Klymenko et al. NEOPLASIA
- Low-grade serous carcinoma of the ovary or peritoneum
- (2016) D. M. Gershenson ANNALS OF ONCOLOGY
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alexi A. Wright et al. JOURNAL OF CLINICAL ONCOLOGY
- The pro-adhesive and pro-survival effects of glucocorticoid in human ovarian cancer cells
- (2016) Lijuan Yin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
- (2015) Anne M. Noonan et al. CANCER
- Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma
- (2015) Erica M. Stringer-Reasor et al. GYNECOLOGIC ONCOLOGY
- Diurnal cortisol and survival in epithelial ovarian cancer
- (2015) Andrew Schrepf et al. PSYCHONEUROENDOCRINOLOGY
- Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
- (2014) Jeffrey R. Infante et al. JOURNAL OF CLINICAL ONCOLOGY
- Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF- B Activation, and Is Active in Patient-Derived Xenograft Models
- (2014) C. A. Benetatos et al. MOLECULAR CANCER THERAPEUTICS
- Small-molecule SMAC mimetics as new cancer therapeutics
- (2014) Longchuan Bai et al. PHARMACOLOGY & THERAPEUTICS
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROR1 expression correlated with poor clinical outcome in human ovarian cancer
- (2014) Huilin Zhang et al. Scientific Reports
- Reduction of Cancer-Related Fatigue With Dexamethasone: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Advanced Cancer
- (2013) Sriram Yennurajalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Glucocorticoid receptor signaling in health and disease
- (2013) Mahita Kadmiel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
- (2013) T. Pemovska et al. Cancer Discovery
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
- (2012) Hifzur Rahman Siddique et al. STEM CELLS
- A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
- (2011) Qian Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Administration of Glucocorticoids to Ovarian Cancer Patients Is Associated with Expression of the Anti-apoptotic Genes SGK1 and MKP1/DUSP1 in Ovarian Tissues
- (2009) A. Melhem et al. CLINICAL CANCER RESEARCH
- Multicellular spheroids in ovarian cancer metastases: Biology and pathology
- (2009) Kristy Shield et al. GYNECOLOGIC ONCOLOGY
- KEGG for representation and analysis of molecular networks involving diseases and drugs
- (2009) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Loss of tight junction barrier function and its role in cancer metastasis
- (2008) Tracey A. Martin et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More